These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22051859)

  • 81. Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants.
    Rice ML; Zeldow B; Siberry GK; Purswani M; Malee K; Hoffman HJ; Frederick T; Buchanan A; Sirois PA; Allison SM; Williams PL;
    Pediatr Infect Dis J; 2013 Oct; 32(10):e406-13. PubMed ID: 24067563
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Mother-to-child HIV-transmission prevention programs in a sub-Saharan African setting: The Gabonese experience.
    Mintsa-Ndong A; Ndong-Ella C; Boussougou RK; Busugu LM; Mba A; Agwambouet FA; Barro N; Djoba Siawaya JF
    Int J STD AIDS; 2018 Mar; 29(3):221-226. PubMed ID: 28758568
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.
    Newell ML; Borja MC; Peckham C;
    Pediatrics; 2003 Jan; 111(1):e52-60. PubMed ID: 12509595
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Neurodevelopment of HIV-exposed uninfected children in Cape Town, South Africa.
    Madlala HP; Myer L; Malaba TR; Newell ML
    PLoS One; 2020; 15(11):e0242244. PubMed ID: 33206724
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.
    Marazzi MC; Nielsen-Saines K; Buonomo E; Scarcella P; Germano P; Majid NA; Zimba I; Ceffa S; Palombi L
    Pediatr Infect Dis J; 2009 Jun; 28(6):483-7. PubMed ID: 19483516
    [TBL] [Abstract][Full Text] [Related]  

  • 86. HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme.
    Haas AD; van Oosterhout JJ; Tenthani L; Jahn A; Zwahlen M; Msukwa MT; Davies MA; Tal K; Phiri N; Spoerri A; Chimbwandira F; Egger M; Keiser O
    J Int AIDS Soc; 2017 Sep; 20(1):21947. PubMed ID: 28884524
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.
    Chaudhury S; Williams PL; Mayondi GK; Leidner J; Holding P; Tepper V; Nichols S; Magetse J; Sakoi M; Moabi K; Makhema J; Mdluli C; Jibril H; Seage GR; Kammerer B; Lockman S
    Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28912368
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Disclosing
    Jao J; Hazra R; Mellins CA; Remien RH; Abrams EJ
    J Int AIDS Soc; 2016; 19(1):21099. PubMed ID: 27741954
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015.
    Williams PL; Huo Y; Rutstein R; Hazra R; Rough K; Van Dyke RB; Chadwick EG
    AIDS Patient Care STDS; 2018 Feb; 32(2):48-57. PubMed ID: 30346801
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Metabolic complications associated with antiretroviral therapy in HIV-infected and HIV-exposed uninfected paediatric patients.
    Viganò A; Cerini C; Pattarino G; Fasan S; Zuccotti GV
    Expert Opin Drug Saf; 2010 May; 9(3):431-45. PubMed ID: 20078250
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants.
    Mofenson LM; Munderi P
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):200-15. PubMed ID: 12045684
    [TBL] [Abstract][Full Text] [Related]  

  • 92. In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers.
    Viganò A; Mora S; Giacomet V; Stucchi S; Manfredini V; Gabiano C; Salvini F; Cellini M; Tamburrini E; Puzzovio M; Zuccotti GV
    Antivir Ther; 2011; 16(8):1259-66. PubMed ID: 22155907
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Fetal Metabolic Stress Disrupts Immune Homeostasis and Induces Proinflammatory Responses in Human Immunodeficiency Virus Type 1- and Combination Antiretroviral Therapy-Exposed Infants.
    Schoeman JC; Moutloatse GP; Harms AC; Vreeken RJ; Scherpbier HJ; Van Leeuwen L; Kuijpers TW; Reinecke CJ; Berger R; Hankemeier T; Bunders MJ
    J Infect Dis; 2017 Aug; 216(4):436-446. PubMed ID: 28633455
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Antiretroviral Prescribing Practices Among Pregnant Women Living With HIV in the United States, 2008-2017.
    Powis KM; Huo Y; Williams PL; Kacanek D; Jao J; Patel K; Seage GR; Van Dyke RB; Chadwick EG;
    JAMA Netw Open; 2019 Dec; 2(12):e1917669. PubMed ID: 31851347
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinical and immunologic characteristics and therapeutic interventions in children born to human immunodeficiency virus-infected mothers in southern Taiwan.
    Lin HC; Wang SM; Wu CS; Chang FM; Liu CC
    J Microbiol Immunol Infect; 2005 Apr; 38(2):89-95. PubMed ID: 15843852
    [TBL] [Abstract][Full Text] [Related]  

  • 96. HIV Viremia During Pregnancy and Neurodevelopment of HIV-Exposed Uninfected Children in the Context of Universal Antiretroviral Therapy and Breastfeeding: A Prospective Study.
    le Roux SM; Donald KA; Kroon M; Phillips TK; Lesosky M; Esterhuyse L; Zerbe A; Brittain K; Abrams EJ; Myer L
    Pediatr Infect Dis J; 2019 Jan; 38(1):70-75. PubMed ID: 30234792
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Risks associated with mother-to-child transmission of HIV infection.
    Nguefack F; Ndombo PK; Ngoh R; Fru FS; Kinkela MN; Chiabi A
    Turk J Pediatr; 2017; 59(4):426-433. PubMed ID: 29624223
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009.
    Namukwaya Z; Mudiope P; Kekitiinwa A; Musoke P; Matovu J; Kayma S; Salmond W; Bitarakwate E; Mubiru M; Maganda A; Galla M; Byamugisha J; Fowler MG
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):69-75. PubMed ID: 21099692
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Mortality risk and associated factors in HIV-exposed, uninfected children.
    Arikawa S; Rollins N; Newell ML; Becquet R
    Trop Med Int Health; 2016 Jun; 21(6):720-34. PubMed ID: 27091659
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.
    Olagunju A; Owen A; Cressey TR
    Pharmacogenomics; 2012 Oct; 13(13):1501-22. PubMed ID: 23057550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.